Verbatim response from Claude
This is a fast-moving area, so I want to be straightforward with you:
Important Context First
The FDA declared the semaglutide shortage officially over in early 2025, which means compounding pharmacies legally cannot compound copies of brand-name semaglutide (Ozempic/Wegovy) for most patients. Tirzepatide's status has been similarly affected.
What's Currently Happening
Many telehealth platforms are transitioning or have already stopped offering compounded GLP-1s, including Hims & Hers and others who received warning letters.
Options Still Worth Investigating
- Ro - has been navigating this space and offering branded alternatives
- Found - focuses on comprehensive obesity medicine
- Calibrate - metabolic health program
- LifeMD/Rocky - has been active in this space
- Henry Meds - worth checking their current offerings
My Honest Recommendation
- Verify current status directly - this changes week to week
- Be cautious of services still aggressively advertising compounded semaglutide, as they may be operating in legally gray territory
- Consider legitimate branded medications through insurance or manufacturer savings programs (Novo Nordisk and Eli Lilly both offer these)
Would you like help finding legitimate access to branded GLP-1 medications instead? That may be a safer path right now.